USFDA issues EIR for Alkem Laboratories’ Baddi facilities

13 Mar 2020 Evaluate

The United States Food and Drug Administration (USFDA) has issued an Establishment Inspection Report (EIR) for the Alkem Laboratories’ manufacturing facility located at Baddi, which was inspected from February 17, 2020 to February 21, 2020. The inspection has now been closed by the USFDA.

Alkem Laboratories is a leading Indian pharmaceutical company with global operations, engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products. The company produces branded generics, generic drugs, active pharmaceutical Ingredients (APIs) and nutraceuticals, which it markets in India and International markets.

Alkem Laboratories Share Price

5765.40 107.60 (1.90%)
22-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1634.40
Dr. Reddys Lab 1217.15
Cipla 1371.55
Zydus Lifesciences 884.85
Lupin 2165.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×